Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Radiological response"'
Publikováno v:
Endocrine Oncology, Vol 4, Iss 1, Pp 1-6 (2024)
Background: 177-LuDOTATE is an effective but expensive treatment for neuroendocrine tumors (NETs). Reducing treatment-related costs, such as the number of images, could improve access to 177-LuDOTATE. We evaluated early radiological tumor progression
Externí odkaz:
https://doaj.org/article/c42e89e9495a4b08808102baf264cd56
Autor:
Hüseyin Tuğsan Ballı, Ferhat Can Pişkin, Sevinç Püren Yücel, Sinan Sözütok, Duygu Özgül, Kairgeldy Aikimbaev
Publikováno v:
Diagnostic and Interventional Radiology, Vol 30, Iss 3, Pp 193-199 (2024)
PURPOSE: The study aims to investigate the predictability of the radiological response in intrahepatic cholangiocarcinoma (iCC) patients undergoing Yttrium-90 transarterial radioembolization (TARE) with a combined model built on dynamic magnetic reso
Externí odkaz:
https://doaj.org/article/dc992d2425c9478f9cd0b004fc22c6a0
Autor:
Adela-Luciana Oprea, Bahadir M. Gulluoglu, Rares Georgescu, Tiberiu-Bogdan Szekely, Alexandra-Daniela Sava, Andra-Diana Popa, Claudiu Marginean
Publikováno v:
Romanian Journal of Medical Practice, Vol 18, Iss 2, Pp 72-78 (2023)
Aim. The aim of our study was to assess the accuracy of a combination of digital mammography and breast ultrasonography in the prediction of response to neoadjuvant systemic treatment in breast cancer patients with different tumor subtypes. Methods.
Externí odkaz:
https://doaj.org/article/074db962f3614a4eb1cf66f838ba6e8d
Publikováno v:
PeerJ, Vol 11, p e15988 (2023)
Background The significance of the current study was to determine normative levels of PIVKA-II and AFP in patients with unresectable HCC and healthy participants. The second goal was to assess the roles of PIVKA-II and AFP in predicting radiological
Externí odkaz:
https://doaj.org/article/7e9929b2c6554a448feed2ac8f124c88
Autor:
Anand V. Kulkarni, Harshvardhan Tevethia, Karan Kumar, Madhumita Premkumar, Mark D. Muttaiah, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, Satoru Kakizaki, Arndt Vogel, Richard S. Finn, Padaki Nagaraja Rao, Anjana Pillai, Duvvur Nageshwar Reddy, Amit G. Singal
Publikováno v:
EClinicalMedicine, Vol 63, Iss , Pp 102179- (2023)
Summary: Background: Atezolizumab-bevacizumab (atezo-bev) is recommended as first-line therapy for patients with unresectable hepatocellular carcinoma (uHCC). However, its effectiveness and safety in other populations, including those with Child-Turc
Externí odkaz:
https://doaj.org/article/ea732d774da342e591c1f6808e94fa44
Autor:
Parvez Ahmed, Nasreen Naz, Amjad Sattar, Nauman al Qamari, Imtiaz Ali, Faryal Farooq, Muhammad Asadullah, Rakesh Kumar
Publikováno v:
Proceedings, Vol 37, Iss 3 (2023)
Introduction: Trans-arterial chemoembolization (TACE) is a mainstay therapeutic option indicated in early-stage non- resectable hepatocellular carcinoma (HCC) and has been shown to be associated with survival improvements. This study aimed to evaluat
Externí odkaz:
https://doaj.org/article/4cb89324beeb47c0915b10993e95ea5b
Autor:
Kai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Hirotaka Horiguchi, Yoshiharu Okuyama, Naoki Fujita, Teppei Okamoto, Akiko Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
BJUI Compass, Vol 3, Iss 2, Pp 139-145 (2022)
Abstract Objectives To investigate the eligibility for maintenance immunotherapy and its impact on the prognosis of advanced urothelial carcinoma treated with first‐line chemotherapy, as the selection biases of the eligible population in the JAVELI
Externí odkaz:
https://doaj.org/article/857c205233624511ba6c913939492daf
Publikováno v:
Asian Pacific Journal of Cancer Care, Vol 6, Iss 2, Pp 159-165 (2021)
Aim: To compare the effect of two RT schedules for thoracic palliation in advanced NSCLC patients (30 Gy in 10 fractions over two weeks and 27 Gy in 6 fractions over three weeks, 2 fractions per week) on pulmonary symptoms, radiological response of t
Externí odkaz:
https://doaj.org/article/12b888c9ef764a47a65bac9cad1cb629
Autor:
Quirino Lai, Andre Viveiros, Samuele Iesari, Alessandro Vitale, Gianluca Mennini, Simona Onali, Maria Hoppe-Lotichius, Marco Colasanti, Tommaso M. Manzia, Federico Mocchegiani, Gabriele Spoletini, Salvatore Agnes, Marco Vivarelli, Giuseppe Tisone, Giuseppe M. Ettorre, Jens Mittler, Emmanuel Tsochatzis, Massimo Rossi, Umberto Cillo, Benedikt Schaefer, Jan P. Lerut
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundLong-term survival after liver transplantation (LT) for hepatocellular cancer (HCC) continues to increase along with the modification of inclusion criteria. This study aimed at identifying risk factors for 5- and 10-year overall and HCC-spe
Externí odkaz:
https://doaj.org/article/e847f04a1f3d45208238054af4e44783
Autor:
Guo‐Ying Liu, Wang‐Zhong Li, Kang‐Qiang Peng, Xing Lv, Liang‐Ru Ke, Yi‐Shan Wu, De‐Ling Wang, Hu Liang, Kui‐Yuan Liu, Shu‐Hui Lv, Xiang Guo, Yan‐Qun Xiang, Wei‐Xiong Xia
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 920-930 (2020)
Abstract Background To explore the prognostic value of early radiological response (ERR) to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma (mNPC), as well as its correlation with the best radiolog
Externí odkaz:
https://doaj.org/article/0fc9b1ce5110430abfbceff814ed02cf